KV Pharmaceuticals Settles Derivative Suit
KV Pharmaceuticals Inc. will soon put its stock options backdating litigation behind it, after reaching a settlement with shareholders who brought a derivative suit against the company's directors....To view the full article, register now.
Already a subscriber? Click here to view full article